BIM
KURA icon

BlackRock Investment Management’s Kura Oncology KURA Stock Holding History

BlackRock Investment Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$15K Hold
2,529
– – ﹤0.01% 3464
2016
Q3 		$16K Hold
2,529
– – ﹤0.01% 3419
2016
Q2 		$7K Buy
+2,529
New +$7.87K ﹤0.01% 3764

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BlackRock Investment Management's KURA Position: Q4 2016 in Review

BlackRock Investment Management held its Kura Oncology (KURA) position steady in Q4 2016 at 2,529 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #3464.

BlackRock Investment Management first reported a position in KURA in Q2 2016 and has held it in 3 quarters since. The position peaked at $16K in Q3 2016. 30 funds tracked by Wall St. Rank hold KURA as of Q4 2016.

  • BlackRock Investment Management held 2,529 shares of Kura Oncology worth $15K as of Q4 2016.
  • BlackRock Investment Management left its Kura Oncology share count unchanged in Q4 2016.
  • Kura Oncology made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3464 holding.
  • BlackRock Investment Management first reported a position in Kura Oncology in Q2 2016 and has held it in 3 quarters since.
  • BlackRock Investment Management's Kura Oncology position peaked at $16K in Q3 2016.
  • 30 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.